Gritstone Oncology to Webcast Presentations from Two Upcoming Investor Conferences in September
September 08 2020 - 8:00AM
Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage
biotechnology company developing the next generation of cancer
immunotherapies to fight multiple cancer types, today announced
that Andrew Allen, M.D., Ph.D., co-founder, president and chief
executive officer, will present a webcasted company overview at two
upcoming investor conferences in September.
- H.C. Wainwright 22nd Annual Global Investment Conference on
Monday, September 14, 2020 at 10:30 a.m. ET
- Cantor Virtual Global Healthcare Conference on Thursday,
September 17, 2020 at 9:20 a.m. ET
A live webcast will be available within the Investors &
Media section of the Gritstone Oncology website at
https://ir.gritstoneoncology.com/investors/events. An archived
replay will be accessible for 30 days following the event.
About Gritstone Oncology Gritstone Oncology
(Nasdaq: GRTS), a clinical-stage biotechnology company, is
developing the next generation of cancer immunotherapies to fight
multiple cancer types. Gritstone develops its products by
leveraging two key pillars—second, a proprietary machine
learning-based platform, Gritstone EDGETM, which is designed to
predict, from a routine tumor biopsy, the tumor-specific
neoantigens (TSNA) that are presented on a patient’s tumor cells;
and second, the ability to develop and manufacture potent
immunotherapies utilizing patients’ TSNA to potentially drive the
patient’s immune system to specifically attack and destroy tumors.
The company’s individualized neoantigen-based immunotherapy,
GRANITE, and its “off the shelf” shared neoantigen-based
immunotherapy, SLATE, are being evaluated in clinical studies.
Novel tumor-specific antigens can also provide targets for
bispecific antibody (BiSAb) therapeutics for solid tumors, and
Gritstone’s BiSAb program is currently in lead optimization. For
more information, please visit gritstoneoncology.com.
Contacts Media: Dan Budwick 1AB (973) 271-6085
dan@1abmedia.com
Investors: Alexandra Santos Wheelhouse Life Science Advisors
(510) 871-6161 asantos@wheelhouselsa.com
Gritstone bio (NASDAQ:GRTS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gritstone bio (NASDAQ:GRTS)
Historical Stock Chart
From Apr 2023 to Apr 2024